3ce Duo Color Face Blush Creme De Violette
NDC Package 60764-059-02

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

3ce Duo Color Face Blush Creme De Violette is a medication used as Purpose: Sunscreen. Marketed by Nanda Co., Ltd, this product is identified by NDC 60764-059 and is authorized under FDA application part352.

Identification & Billing

NDC Package Code
60764-059-02
Package Description
1 CONTAINER in 1 CARTON / 5 g in 1 CONTAINER (60764-059-01)
Product Code
60764-059
11-Digit Billing Format
60764005902

Clinical Specifications

Proprietary Name
3ce Duo Color Face Blush Creme De Violette
Dosage Form
-
Usage Information
This product is used as Purpose: Sunscreen

Regulatory & Marketing

Labeler Name
Nanda Co., Ltd
FDA Application #
part352
Marketing Category
OTC MONOGRAPH NOT FINAL - A product marketed pursuant to an Over-the-Counter (OTC) Drug Monograph that is not final.
Start Marketing Date
08-20-2016
Listing Expiration
12-31-2018
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 60764-059-02 identifies a specific commercial package of 1 container in 1 carton / 5 g in 1 container (60764-059-01) of 3ce Duo Color Face Blush Creme De Violette, labeled by Nanda Co., Ltd. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Nanda Co., Ltd on August 20, 2016. The current certification is valid through December 31, 2018.

How is this Nanda Co., Ltd product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 60764005902. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
60764-059-02
11-Digit CMS (5-4-2)
60764-0059-02

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.